NDT Pharmaceuticals (NDT Pharmaceuticals) EV-to-EBITDA : -96.78 (As of Jun. 22, 2024)

NDT Pharmaceuticals EV-to-EBITDA Chart

NDT Pharmaceuticals Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08
EV-to-EBITDA	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of NDT Pharmaceuticals's EV-to-EBITDA

For the Biotechnology subindustry, NDT Pharmaceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NDT Pharmaceuticals's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NDT Pharmaceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where NDT Pharmaceuticals's EV-to-EBITDA falls into.

NDT Pharmaceuticals EV-to-EBITDA Calculation

NDT Pharmaceuticals's EV-to-EBITDA for today is calculated as:

NDT Pharmaceuticals's current Enterprise Value is $24.00 Mil.
NDT Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Jun. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NDT Pharmaceuticals  (OTCPK:NDTP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

NDT Pharmaceuticals's PE Ratio for today is calculated as:

NDT Pharmaceuticals's share price for today is $0.15.
NDT Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-30.426.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

NDT Pharmaceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of NDT Pharmaceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

NDT Pharmaceuticals (NDT Pharmaceuticals) Business Description